Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000886744-26-000037
Filing Date
2026-08-05
Accepted
2026-08-05 16:41:53
Documents
63
Period of Report
2026-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q gern-20260630.htm   iXBRL 10-Q 1577804
2 EX-10.1 a2026severanceplan.htm EX-10.1 147005
3 EX-31.1 gern-20260630xexx311.htm EX-31.1 10284
4 EX-31.2 gern-20260630xexx312.htm EX-31.2 10430
5 EX-32.1 gern-20260630xexx321.htm EX-32.1 5122
6 EX-32.2 gern-20260630xexx322.htm EX-32.2 5235
  Complete submission text file 0000886744-26-000037.txt   6908367

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT gern-20260630.xsd EX-101.SCH 39511
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT gern-20260630_cal.xml EX-101.CAL 79061
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT gern-20260630_def.xml EX-101.DEF 154021
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT gern-20260630_lab.xml EX-101.LAB 517396
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT gern-20260630_pre.xml EX-101.PRE 330345
67 EXTRACTED XBRL INSTANCE DOCUMENT gern-20260630_htm.xml XML 991636
Mailing Address 919 EAST HILLSDALE BOULEVARD SUITE 250 FOSTER CITY CA 94404
Business Address 919 EAST HILLSDALE BOULEVARD SUITE 250 FOSTER CITY CA 94404 6504737700
GERON CORP (Filer) CIK: 0000886744 (see all company filings)

EIN.: 752287752 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-20859 | Film No.: 261244312
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)